[go: up one dir, main page]

NO20010861D0 - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20010861D0
NO20010861D0 NO20010861A NO20010861A NO20010861D0 NO 20010861 D0 NO20010861 D0 NO 20010861D0 NO 20010861 A NO20010861 A NO 20010861A NO 20010861 A NO20010861 A NO 20010861A NO 20010861 D0 NO20010861 D0 NO 20010861D0
Authority
NO
Norway
Prior art keywords
new connections
connections
new
Prior art date
Application number
NO20010861A
Other languages
English (en)
Other versions
NO20010861L (no
Inventor
Amin Kosrat
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20010861D0 publication Critical patent/NO20010861D0/no
Publication of NO20010861L publication Critical patent/NO20010861L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20010861A 1998-08-21 2001-02-20 Nye forbindelser NO20010861L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802793A SE9802793D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001401 WO2000010999A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (2)

Publication Number Publication Date
NO20010861D0 true NO20010861D0 (no) 2001-02-20
NO20010861L NO20010861L (no) 2001-04-10

Family

ID=20412306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010861A NO20010861L (no) 1998-08-21 2001-02-20 Nye forbindelser

Country Status (21)

Country Link
US (1) US6613775B1 (no)
EP (1) EP1105390B1 (no)
JP (1) JP2002523414A (no)
KR (1) KR20010072797A (no)
CN (1) CN1161355C (no)
AR (1) AR020225A1 (no)
AT (1) ATE242242T1 (no)
AU (1) AU770511B2 (no)
BR (1) BR9913102A (no)
CA (1) CA2339372A1 (no)
DE (1) DE69908608T2 (no)
DK (1) DK1105390T3 (no)
ES (1) ES2201769T3 (no)
IL (1) IL141165A0 (no)
MY (1) MY121387A (no)
NO (1) NO20010861L (no)
NZ (1) NZ509744A (no)
PT (1) PT1105390E (no)
SE (1) SE9802793D0 (no)
WO (1) WO2000010999A2 (no)
ZA (1) ZA200100911B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
HRP20050399B1 (hr) 2003-03-10 2013-09-30 Takeda Gmbh Novi postupci za dobivanje roflumilasta
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060194782A1 (en) * 2003-09-18 2006-08-31 Altana Pharma Ag Pharmacologically active imidazo[4,5-c] pyridines
US20080280944A1 (en) 2003-11-03 2008-11-13 Paula Fernstrom Imidazo[1,2-A]Pyridine Derivatives For The Treatment Of Silent Gastro-Esophageal Reflux
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006013195A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1h-pyrrolo[3,2-b]pyridines
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
US8663694B2 (en) 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
PE20061110A1 (es) * 2005-03-24 2006-10-20 Glaxo Group Ltd Derivados de imidazopiridina como antagonistas de la bomba de acido (apa)
CA2766643C (en) 2009-07-08 2017-01-03 Dermira (Canada), Inc. Tofa analogs useful in treating dermatological disorders or conditions
RU2586276C2 (ru) 2009-07-09 2016-06-10 Раквалиа Фарма Инк. Антагонист кислотного насоса для лечения заболеваний, связанных с патологическим нарушением моторики желудочно-кишечного тракта

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers

Also Published As

Publication number Publication date
WO2000010999A3 (en) 2000-06-02
AU5767899A (en) 2000-03-14
US6613775B1 (en) 2003-09-02
EP1105390B1 (en) 2003-06-04
IL141165A0 (en) 2002-11-10
BR9913102A (pt) 2001-05-08
JP2002523414A (ja) 2002-07-30
CA2339372A1 (en) 2000-03-02
WO2000010999A2 (en) 2000-03-02
CN1161355C (zh) 2004-08-11
AU770511B2 (en) 2004-02-26
MY121387A (en) 2006-01-28
EP1105390A2 (en) 2001-06-13
DE69908608T2 (de) 2004-04-29
AR020225A1 (es) 2002-05-02
SE9802793D0 (sv) 1998-08-21
ES2201769T3 (es) 2004-03-16
CN1323308A (zh) 2001-11-21
KR20010072797A (ko) 2001-07-31
DE69908608D1 (de) 2003-07-10
ZA200100911B (en) 2002-05-02
ATE242242T1 (de) 2003-06-15
NO20010861L (no) 2001-04-10
NZ509744A (en) 2003-05-30
DK1105390T3 (da) 2003-09-22
HK1036274A1 (en) 2001-12-28
PT1105390E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
NO20000312L (no) Nye forbindelser
NO20014518L (no) Nye forbindelser
DK1202994T3 (da) Nye forbindelser
NO20002787D0 (no) Nye forbindelser
NO20021436D0 (no) Nye forbindelser
NO20005832L (no) Nye spesielle formuleringer
NO20003347D0 (no) Nye macrolider
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
NO20020810D0 (no) Nye fenylpiperaziner
ID23287A (id) Trisiklik tersubstitusi
NO20015383D0 (no) Nye forbindelser
NO20010860D0 (no) Nye forbindelser
EP1124578A4 (en) NEW IMMUNOADJUVANTS
DK0906288T3 (da) Nye forbindelser
NO20010861D0 (no) Nye forbindelser
ID23219A (id) Trisiklik tersubstitusi
NO20005857D0 (no) Nye blandinger
NO995945D0 (no) Nye forbindelser
NO20015374L (no) Nye forbindelser
NO20010584D0 (no) Nye forbindelser
NO20011262L (no) Nye forbindelser
NO20014629L (no) Nye forbindelser
NO990072D0 (no) Nye forbindelser
DE59911610D1 (de) Substituierte benzoylcyclohexandione
NO20016273D0 (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application